文献速递胃肠外科围术期管理与 ERAS

儿童青少年袖状胃切除术后十年结局:减重、合并症缓解、不良事件与生长速度

Ten-Year Outcomes of Children and Adolescents Who Underwent Sleeve Gastrectomy: Weight Loss, Comorbidity Resolution, Adverse Events, and Growth Velocity.
PubMed 文献 · J Am Coll Surg · 2021-09-23

该前瞻性队列研究纳入2008至2021年间接受腹腔镜袖状胃切除术(LSG)的2504例II/III级肥胖儿童青少年,分析术后10年减重、生长、合并症缓解及不良事件数据。结果显示短期、中期和长期随访的超重体重减少百分比分别为82.3%±20.5%、76.3%±29.1%和71.1%±26.9%,长期随访中2型糖尿病、血脂异常和高血压完全缓解率分别为74%、59%和64%,身高z评分变化无显著差异,不良事件发生率1%且无手术相关死亡。

要点

  • LSG在儿童青少年中可实现长达10年的持久减重,超重体重减少百分比长期随访达71.1%±26.9%。
  • 长期随访中2型糖尿病、血脂异常和高血压完全缓解率分别为74%、59%和64%。
  • 生长速度未受显著影响,不良事件发生率1%,无手术相关死亡。

核心结论

  • 儿童青少年LSG术后长期随访显示减重持久、合并症缓解维持且生长未受改变。

研究设计与样本

  • 前瞻性队列研究,纳入2008至2021年间接受LSG的2504例II/III级肥胖儿童青少年,年龄5至21岁,55%为女性。

主要发现

  • 短期(1至3年,n=2051)、中期(4至6年,n=1268)和长期(7至10年,n=632)随访的超重体重减少百分比分别为82.3%±20.5%、76.3%±29.1%和71.1%±26.9%。
  • 长期随访中2型糖尿病、血脂异常和高血压完全缓解率分别为74%、59%和64%。
  • 短期、中期和长期随访的身高z评分变化分别为0.1±0.5、0.1±1.2和0.0±0.8,生长速度无显著改变。
  • 共发生27例不良事件(1%),无手术相关死亡。

临床怎么用

  • 对于严重肥胖的儿童青少年,LSG可考虑作为实现持久减重和合并症缓解的治疗选择,但需关注长期不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To date, there are insufficient data on long-term outcomes of weight loss surgery in children and adolescents with obesity beyond 5 years of follow-up. This study aimed to analyze durability of weight loss and comorbidity resolution, growth velocity, and adverse events associated with laparoscopic sleeve gastrectomy (LSG) in children and adolescents with severe obesity. STUDY DESIGN: In this prospective cohort study, 2,504 children and adolescents with class II/III obesity who were enrolled in a multidisciplinary, family-based pediatric obesity management program underwent LSG between 2008 and 2021. Weight loss, growth, comorbidity resolution, and adverse event data during the first 10 years after LSG were analyzed. RESULTS: The cohort age was 5 to 21 years at the time of operation, and 55% were female. Mean ± SD percentage of excess weight lost during short- (1 to 3 years; n = 2,051), medium- (4 to 6 years; n = 1,268), and long-term (7 to 10 years; n = 632) follow-up was 82.3% ± 20.5%, 76.3% ± 29.1%, and 71.1% ± 26.9%, respectively. Complete comorbidity remission at long-term follow-up was observed in 74%, 59%, and 64% of type 2 diabetes, dyslipidemia, and hypertension cases, respectively. Mean ± SD height z-score change at short-, medium-, and long-term follow-up was 0.1 ± 0.5, 0.1 ± 1.2, and 0.0 ± 0.8, respectively, representing no significant change in growth velocity. There were 27 adverse events (1%) with no procedure-related mortality. CONCLUSIONS: Long-term follow-up after LSG in children and adolescents demonstrates durable weight loss, maintained comorbidity resolution, and unaltered growth.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Alqahtani AR, Elahmedi M, Abdurabu HY, et al. Ten-Year Outcomes of Children and Adolescents Who Underwent Sleeve Gastrectomy: Weight Loss, Comorbidity Resolution, Adverse Events, and Growth Velocity. J Am Coll Surg. 2021. PMID: 34563670. doi:10.1016/j.jamcollsurg.2021.08.678

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。